Evidence map›Paper›PMID 41200610›Full record

ReviewCureus2025

Gut Microbiota-Directed Interventions in Type 2 Diabetes: A Systematic Review of Clinical Outcomes and Complication Risk.

Mustafeez Ur Rehman, Hadia Saeed, Osman Omer, Shahbaz Tashfeen

Abstract readReview
In one paragraph

Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mustafeez Ur RehmanInternal Medicine, Manchester University National Health Service (NHS) Foundation Trust, Manchester, GBR.
Hadia SaeedEmergency Department, King's College Hospital, London, GBR.
Osman OmerIntegrative Medicine, Prince Mohammed Bin Abdulaziz Hospital, Madinah, SAU.
Shahbaz TashfeenInternal Medicine, Nishtar Medical University, Multan, PAK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Type 2 diabetes mellitus is increasingly recognized as a disorder not only of glucose metabolism but also of gut microbial imbalance, with emerging evidence suggesting a bidirectional link between microbiome composition and metabolic dysfunction. Recent randomized controlled trials and dietary interventions highlight that specific microbial taxa, such as butyrate-producing bacteria and

Indexed as

cardiometabolic riskcomplicationsgut microbiotainsulin resistancepersonalized nutritionprebioticsprobioticstype 2 diabetes

Identifiers

PMID41200610
PMCPMC12588258

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.